| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 19 |
| 1 | METFORMIN ER 500 MG | 17 |
| 2 | METFORMIN ER 750 MG | 17 |
| 3 | CYCLOPHOSPHAMIDE | 12 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 6 | DOCETAXEL | 12 |
| 7 | DOCETAXEL ANHYDROUS | 12 |
| 8 | EMPAGLIFLOZIN | 8 |
| 9 | ALOGLIPTIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALOGLIPTIN | 7 | 0.0020 |
| 1 | VALPROATE SODIUM | 6 | 0.0003 |
| 2 | NIACIN | 3 | 0.0003 |
| 3 | DOCETAXEL | 12 | 0.0002 |
| 4 | DOCETAXEL ANHYDROUS | 12 | 0.0002 |
| 5 | METHYLPHENIDATE HYDROCHLORIDE | 7 | 0.0001 |
| 6 | INCLISIRAN | 1 | 0.0001 |
| 7 | EMPAGLIFLOZIN | 8 | 0.0001 |
| 8 | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0.0001 |
| 9 | SITAGLIPTIN | 7 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 6 | 0.0002 |
| 1 | Central Nervous System Stimulant [EPC] | 7 | 0.0001 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Microtubule Inhibitor [EPC] | 12 | 0.0001 |
| 4 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 5 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 12 | 0.0000 |
| 7 | Nicotinic Acid [EPC] | 3 | 0.0000 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |